Dimitra Bon

Sofosbuvir and Ribavirin for Hepatitis C Genotype 1 in Patients With Unfavorable Treatment Characteristics

A. Osinusi, Eric G. Meissner, Y.-J. Lee et al. · JAMA · 2013 · 285 citations · Full text

Patient Blood Management is Associated With a Substantial Reduction of Red Blood Cell Utilization and Safe for Patient's Outcome

Patrick Meybohm, Eva Herrmann, Andrea U. Steinbicker et al. · Annals of Surgery · 2016 · 208 citations

Virologic Response Following Combined Ledipasvir and Sofosbuvir Administration in Patients With HCV Genotype 1 and HIV Co-infection

Anu Osinusi, Kerry Townsend, Anita Kohli et al. · JAMA · 2015 · 203 citations · Full text

Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcome

Eric G. Meissner, David Wu, Anu Osinusi et al. · Journal of Clinical Investigation · 2014 · 200 citations · Full text

Virological response after 6 week triple-drug regimens for hepatitis C: a proof-of-concept phase 2A cohort study

Anita Kohli, A. Osinusi, Zayani Sims et al. · The Lancet · 2015 · 151 citations

Hepatology, Hepatitis C, Week Triple-drug Regimens +9